Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023
Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious diseases, today provided a business update and...